ONCOLOGÍA CLÍNICA
Hospital Severo Ochoa
Madrid, EspañaPublications en collaboration avec des chercheurs de Hospital Severo Ochoa (2)
2024
-
BRAF mutational status is associated with survival outcomes in locally advanced resectable and metastatic NSCLC
Lung Cancer, Vol. 194
-
Olaparib maintenance versus placebo in platinum-sensitive non-small cell lung cancer: the Phase 2 randomized PIPSeN trial
British Journal of Cancer, Vol. 130, Núm. 3, pp. 417-424